AAV-EPO mab (1Q1U) WT Cas9-NAT2 for B Cell Engineering (CAT#: BGS-0524-CR29)

The product is a highly efficient, inducible WT Cas9-NAT2 gene-editing based novel AAV packaging system that can be used to mediate researches involving anti-EPO mab (1Q1U) in Dog B cell engineering.

Datasheet

Specifications

Clone 1Q1U
Host Human
Packaging Cell Line 293SF-PacLV
Vector Promoter CMV
Rep Rep78
Capsid P24
Envelope GP160
Matrix N-terminal
Size ~30kb
Genome ssRNA
Virus Type AAV
Cofactor Requirement No dNTPs
Particles/mL 9.5 × 10¹¹
PFU/mL 5.5 × 10¹¹
TU/mL 3.6 × 10¹¹
Cas9 WT Cas9
sgRNA NAT2
Engineered B Cell Dog B cells

Target Information

Target EPO
Alternative Names Erythropoietin; Epoetin; MVCD2; EP
UniProt ID P01588(Human); P29676(Rat)

Product Properties

Format Liquid
Shipping The product is shipped by dry ice.
Storage Upon receipt, store immediately at -80°C or lower for long-term storage. Avoid freeze/thaw cycles.
COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number
! For Research Use Only | Not For Clinical Use

Related products